CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells

World Journal of Gastroenterology

Volumn 19, Issue 17, 2013, Pages 2621-2628

  Kósa, János P ^a   Horváth, Péter ^a   Wölfing, János ^b   Kovács, Dóra ^b   Balla, Bernadett ^a   Mátyus, Péter ^a   Horváth, Evelin ^a   Speer, Gábor ^a   Takács, István ^a   Nagy, Zsolt ^a   Horváth, Henrik ^a   Lakatos, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Caco 2 cell culture; Colorectal cancer; CYP24A1 inhibition; Tetralone derivatives; Vitamin D3

Indexed keywords

CALCIFEDIOL; COLECALCIFEROL; CYTOCHROME; CYTOCHROME P450 24A1; LACTATE DEHYDROGENASE; MESSENGER RNA; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

EID: 84877352563     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i17.2621     Document Type: Article

References (40)

1. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rin-aldi S, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Tricho-poulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodríguez L, Sánchez MJ, Dorron-soro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010; 340: b5500 [PMID: 20093284 DOI: 10.1136/bmj.b5500]
2. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 2000; 11: 459-466 [PMID: 10877339 DOI: 10.1023/A: 1008914108739]
3. Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr 2005; 135: 2350-2354 [PMID: 16177194]
4. Zeeb H, Greinert R. The role of vitamin D in cancer prevention: does UV protection conflict with the need to raise low levels of vitamin D? Dtsch Arztebl Int 2010; 107: 638-643 [PMID: 20959891]
5. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-781 [PMID: 20116997 DOI: 10.1016/ j.ejca.2009.12.014]
6. Cross HS, Nittke T, Peterlik M. Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention. Anticancer Res 2009; 29: 3705-3712 [PMID: 19667168]
7. Giovannucci E. Strengths and limitations of current epide-miologic studies: vitamin D as a modifer of colon and prostate cancer risk. Nutr Rev 2007; 65: S77-S79 [PMID: 17867375 DOI: 10.1301/nr.2007.aug.S77-S79]
8. Rheem DS, Baylink DJ, Olafsson S, Jackson CS, Walter MH. Prevention of colorectal cancer with vitamin D. Scand J Gas-troenterol 2010; 45: 775-784 [PMID: 20367197 DOI: 10.3109/00 365521003734125]
9. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128: 1414-1424 [PMID: 20473927 DOI: 10.1002/ijc.25439]
10. Wada K, Tanaka H, Maeda K, Inoue T, Noda E, Amano R, Kubo N, Muguruma K, Yamada N, Yashiro M, Sawada T, Nakata B, Ohira M, Hirakawa K. Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep 2009; 22: 1021-1025 [PMID: 19787215]
11. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carci-nogenesis 2009; 30: 88-92 [PMID: 19017685 DOI: 10.1093/car-cin/bgn229]
12. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Bio-markers Prev 2004; 13: 1502-1508 [PMID: 15342452]
13. Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol 2006; 22: 24-29 [PMID: 16319673 DOI:10.1097/01.mog.0000196150.36701.c2]
14. Ordóñez-Morán P, Muñoz A. Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 2009; 8: 1675-1680 [PMID: 19448403 DOI: 10.4161/cc.8.11.8579]
15. Mikhail N. Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy. South Med J 2011; 104: 29-33 [PMID: 21079532 DOI: 10.1097/SMJ.0b013e3181fcd772]
16. Cho YL, Christensen C, Saunders DE, Lawrence WD, Deppe G, Malviya VK, Malone JM. Combined effects of 1,25-di-hydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells. Cancer Res 1991; 51: 2848-2853 [PMID: 2032225]
17. Liu G, Hu X, Chakrabarty S. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU. Int J Cancer 2010; 126: 631-639 [PMID: 19621386DOI: 10.1002/ijc.24762]
18. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J 1982; 204: 713-719 [PMID: 6289803]
19. Lechner D, Kállay E, Cross HS. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 2007; 263: 55-64 [PMID: 17029768 DOI: 10.1016/j.mce.2006.08.009]
20. Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R, Cross HS. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Exp Cell Res 2002; 276: 320-327 [PMID: 12027461DOI: 10.1006/excr.2002.5528]
21. Ma Y, Trump DL, Johnson CS. Vitamin D in combination cancer treatment. J Cancer 2010; 1: 101-107 [PMID: 20842231 DOI: 10.7150/jca.1.101]
22. Mocellin S. Vitamin D and cancer: deciphering the truth. Biochim Biophys Acta 2011; 1816: 172-178 [PMID: 21767609]
23. Edlich R, Mason SS, Chase ME, Fisher AL, Gubler K, Long WB, Giesy JD, Foley ML. Scientific documentation of the relationship of vitamin D deficiency and the development of cancer. J Environ Pathol Toxicol Oncol 2009; 28: 133-141 [PMID: 19817700 DOI: 10.1615/JEnvironPatholToxicolOncol.v28. i2.50]
24. Horváth HC, Lakatos P, Kósa JP, Bácsi K, Borka K, Bises G, Nittke T, Hershberger PA, Speer G, Kállay E. The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem 2010; 58: 277-285 [PMID: 19901270 DOI: 10.1369/jhc.2009.954339]
25. Larriba MJ, Martín-Villar E, García JM, Pereira F, Peña C, de Herreros AG, Bonilla F, Muñoz A. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis 2009; 30: 1459-1468 [PMID: 19502595 DOI: 10.1093/carcin/bgp140]
26. Aboraia AS, Makowski B, Bahja A, Prosser D, Brancale A, Jones G, Simons C. Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones. Eur J Med Chem 2010; 45: 4427-4434 [PMID: 20655626 DOI: 10.1016/j.ejmech.2010.07.001]
27. Yee SW, Jarno L, Gomaa MS, Elford C, Ooi LL, Coogan MP, McClelland R, Nicholson RI, Evans BA, Brancale A, Simons C. Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver mi-crosomal and MCF-7 CYP26A1 cell assays. J Med Chem 2005; 48: 7123-7131 [PMID: 16279770 DOI: 10.1021/jm0501681]
28. Schuster I, Egger H, Nussbaumer P, Kroemer RT. Inhibitors of vitamin D hydroxylases: structure-activity relationships. J Cell Biochem 2003; 88: 372-380 [PMID: 12520539 DOI: 10.1002/jcb.10365]
29. Ordóñez-Morán P, Larriba MJ, Pálmer HG, Valero RA, Barbáchano A, Duñach M, de Herreros AG, Villalobos C, Berciano MT, Lafarga M, Muñoz A. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 2008; 183: 697-710 [PMID: 19015318 DOI: 10.1083/ jcb.200803020]
30. Peña C, García JM, Silva J, García V, Rodríguez R, Alonso I, Millán I, Salas C, de Herreros AG, Muñoz A, Bonilla F. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 2005; 14: 3361-3370 [PMID: 16203744 DOI: 10.1093/hmg/ddi366]
31. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 2005; 185: 577-592 [PMID:15930183 DOI: 10.1677/joe.1.05770]
32. Gilad LA, Tirosh O, Schwartz B. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells. J Endocrinol 2006; 191: 387-398 [PMID: 17088408 DOI: 10.1677/joe.1.06930]
33. Lechner D, Bajna E, Adlercreutz H, Cross HS. Genistein and 17beta-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res 2006; 26: 2597-2603 [PMID: 16886669]
34. Larriba MJ, Muñoz A. SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer 2005; 92: 985-989 [PMID: 15770204 DOI: 10.1038/ sj.bjc.6602484]
35. Pálmer HG, Larriba MJ, García JM, Ordóñez-Morán P, Peña C, Peiró S, Puig I, Rodríguez R, de la Fuente R, Bernad A, Pollán M, Bonilla F, Gamallo C, de Herreros AG, Muñoz A. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 2004; 10: 917-919 [PMID: 15322538 DOI: 10.1038/ nm1095]
36. Tashiro K, Abe T, Oue N, Yasui W, Ryoji M. Characterization of vitamin D-mediated induction of the CYP 24 transcription. Mol Cell Endocrinol 2004; 226: 27-32 [PMID: 15489002 DOI: 10.1016/j.mce.2004.07.012]
37. Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. J Biol Chem 2010; 285: 15599-15610 [PMID: 20236932 DOI: 10.1074/jbc.M110.119958]
38. Chen KS, DeLuca HF. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995; 1263: 1-9 [PMID: 7632726 DOI: 10.1016/01 67-4781(95)00060-T]
39. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478 [PMID: 20133466 DOI: 10.1210/ jc.2009-1773]
40. Ordóñez-Morán P, Alvarez-Díaz S, Valle N, Larriba MJ, Bo-nilla F, Muñoz A. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling. J Steroid Biochem Mol Biol 2010; 121: 355-361 [PMID: 20223287 DOI: 10.1016/j.jsbmb.2010.02.031]